Equities

Bio-Gate AG

Bio-Gate AG

Actions
  • Price (EUR)0.91
  • Today's Change0.00 / 0.00%
  • Shares traded2.00k
  • 1 Year change-55.83%
  • Beta--
Data delayed at least 15 minutes, as of May 03 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bio-Gate AG is a Germany-based medical technology company. The Company employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. It produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of implants, skin care, cosmetics, orthopedics, industrial applications, consumer goods, would care, textiles and dental products. The Company incorporates silver particles into cosmetics, paints, veneers or plastics, or involves coating of final products, such as implants or wound dressings, with a silver-containing functional layer.

  • Revenue in EUR (TTM)6.60m
  • Net income in EUR-1.45m
  • Incorporated2005
  • Employees38.00
  • Location
    Bio-Gate AGNeumeyerstrasse 28-34NUERNBERG 90411GermanyDEU
  • Phone+49 911 477523100
  • Fax+49 911 477523101
  • Websitehttps://www.bio-gate.de/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.